Clinical Trials Browser

Phase 1/2 × Lymphoma, Large B-Cell, Diffuse × glofitamab × Clear all

NCT05896163 2026-05-06

MAPtivate-6

Phase 1/2 Terminated

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04914741 2024-08-12

COALITION

Phase 1/2 Active not recruiting

Lymphoma, Large B-Cell, Diffuse